Uncategorized

Palatin Technologies, Inc. today announced The International Journal of Molecular Sciences published a manuscript, “Stimulating the Melanocortin System in Uveitis and Diabetes Preserves the Structure and Anti-Inflammatory Activity of the Retina” by Tat Fong Ng and Andrew W. Taylor from Department of Ophthalmology, Boston University Chobanian and Avedisian School of Medicine, in Boston, Massachusetts.

A unanimous FDA committee vote supported the favorable risk-benefit profile of Innoviva’s sulbactam-durlobactam for hospital-acquired A. baumannii infections.

Ampio Pharmaceuticals, Inc. released the following letter to stockholders from its Chairman, Kevin Buchi and Chief Executive Officer, Mike Martino.

Algunos de los asteroides que Lucy visitará se encuentran aún a más de 530 millones de kilómetros de la nave espacial, lo que supone más del triple de la distancia media entre la Tierra y el Sol. Pero a pesar de la gran distancia y de los tamaños peque&ntild …

El helicóptero robótico Ingenuity de la NASA ha efectuado su vuelo número 50 en Marte. El Ingenuity, que es la primera aeronave en volar en otro mundo, realizó ese vuelo número 50 el 13 de abril, recorriendo más de 322,2 metros en 145,7 segundos.   El …

Ondine Biomedical Inc. presented detailed results from its US Phase 2 BENEFIT-aPDT clinical trial to the 33rd European Congress of Clinical Microbiology and Infectious Diseases in Copenhagen, Denmark.

Nordic Nanovector ASA announces that full results from its Phase 2 clinical trials of Betalutin® in resistant/refractory indolent non-Hodgkin’s lymphoma have been published at EudraCT, the European Union Drug Regulating Authorities Clinical Trials Database of the European Union.

Biophytis SA announces the approval by a very large majority of all resolutions presented by the company and falling within the remit of the Combined General Meeting.

Biophytis SA announces its financial results for the year ended December 31, 2022, and provides updates on key perspectives for 2023.

Lucid Diagnostics Inc. announced that Dr. Lishan Aklog, Chairman and Chief Executive Officer; and Dennis McGrath, Chief Financial Officer will present at the 22nd Annual Needham Healthcare Conference on Thursday, April 20, 2023 at 11:00 AM ET.